Axiron is a newer testosterone treatment, which was introduced by Eli Lilly in 2010 as a competitor for the widely used AndroGel. However, it has proved to be just as dangerous
In 2010, the FDA approved Axiron, manufactured by pharmaceutical giant Eli Lilly. Within one year, sales topped almost $50 million. Eli Lilly is hundreds of millions on marketing campaigns pushing testosterone therapy. However, recent studies discovered that using Axiron users may increase dangerous side effects.
The Journal of the American Medical Association determined that men with naturally low testosterone levels who had a coronary angiography had a 29% increased rate of heart attack, stroke, and death if they used testosterone supplements. Another study published by the Endocrine Society raised additional concerns. Their study shows that doctors are prescribing these supplements to men who don’t even need it.
Testosterone therapy is intended to treat male hypogonadism. This condition is when the body fails to make enough hormones because of a problem with the testicles, pituitary gland or brain. There are a variety of prescription testosterone products available. These come in different forms, including gels, injectable solutions, patches, pills and pellets implanted under the skin. However, once a patient starts testosterone therapy, he must always continue it. Usually, doctors will monitor the patient’s hormone levels every six months to a year. This means big bucks to everyone involved.
In 2013, the Journal of the American Medical Association (JAMA), published an alarming Axiron study. In the study, researchers reviewed data involving 8,700 veterans around age of 60. These veterans had a coronary angiography between 2005 and 2011. All of the men had low testosterone levels. However, those who received a testosterone gel, patch or injection prescription following the surgery were found to be 29% more likely to experience a heart attack, stroke or death.
Another study published in the medical journal PLoS One analyzed data involving almost 60,000 men. The age varied for those involved in the study. in fact, researchers discovered that younger men under the age of 65, who had a prior diagnosis of heart disease, maybe twice as likely to suffer a non-fatal heart attack during the 90 days after they were first prescribed Axiron or another testosterone treatment. The risk for a heart attack doubles in men over the age of 65. This is regardless of any pre-existing heart problems.
Following these studies, the FDA has launched an investigation into the potential health risks associated with Axiron, Androgel and other similar products.
Axiron Side Effects
Although it was marketed as a safe and effective treatment for low testosterone, side effects of Axiron are:
- Heart attack
- Blood clot
- Pulmonary embolism (PE)
- Deep vein thrombosis (DVT)
- Venous thromboembolism (VTE)
- Transient ischemic attacks
- Brain damage
- Sudden death
Testosterone Manufacturers are Accountable
Testosterone therapy industry has turned into a multibillion-dollar industry, with more than 5.3 million prescriptions sold in 2011. Therefore, pharmaceutical drug manufacturers are responsible for informing people of all negative effects and risks associated with their medications. If people are not provided this information, they cannot make the best choices about their health.
In light of this, how many of the men who chose to take these drugs would have made a different decision if they knew this information?
Seek Legal Help
If you or a man you know has suffered adverse cardiac effects as a result of taking testosterone therapy, you should consult with an attorney to explore your legal rights. The Michael Brady Lynch Firm is committed to litigating these cases and placing accountability on the responsible drug manufacturers.
Contact us today by calling (877) 513-9517 or fill out the form for a free consultation. There is no obligation.